Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Registry of Patients Diagnosed With Low-risk Myelodysplastic Syndromes According to the Criteria of the WHO / French-American-British Classification System (FAB) and IPSS and Treated With Erythropoietic Agents.

NCT01739452 is registered in ClinicalTrials.gov with Grupo Español de Síndromes Mielodisplásicos as lead sponsor.

NCT NCT01739452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Registry of Patients Diagnosed With Low-risk Myelodysplastic Syndromes According to the Criteria of the WHO / French-American-British Classification System (FAB) and IPSS and Treated With Erythropoietic Agents.
Lead sponsor
Grupo Español de Síndromes Mielodisplásicos
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2014
Enrollment
722 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome